MedTrace Logo

Study on Surgical Treatment Strategies for Moderate Ischemic Mitral Regurgitation

NCT06408779 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 464

Last updated 2024-05-16

No results posted yet for this study

Summary

This study aimed to compare the efficacy of isolated coronary artery bypass grafting and coronary artery bypass grafting + mitral valve repair in moderate ischemic mitral regurgitation patients through a cohort and explore the potential risk factors of the clinical outcomes.

Conditions

  • Mitral Valve Insufficiency
  • Mitral Valve Annuloplasty
  • Coronary Artery Bypass

Interventions

PROCEDURE

mitral valve repair

coronary artery bypass grafting concomitant mitral valve repair

Sponsors & Collaborators

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2024-04-01
Completion
2024-04-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06408779 on ClinicalTrials.gov